COLGATE PALMOLIVE CO CL
Colgate-Palmolive Company (together with its subsidiaries, "we," "us," "our," the "Company" or "Colgate-Palmolive") is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet. We do this by leveraging the global reach and penetration of our brands; building the incremental benefit of superior, science-based innovation supported by an agile and resilient supply chain; harnessing the power of best-in-class omni-channel demand generation; leading in capabilities such as data, analytics and artificial intelligence ("AI"); and evolving our high-impact, inclusive culture. Our products are marketed in over 200 countries and territories throughout the world. Colgate-Palmolive was founded in 1806 and incorporated under the laws of the State of Delaware in 1923.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B | $15.69B | $15.54B | $15.45B | $15.20B |
| Cost of revenue | $8.13B | $7.94B | $8.13B | $7.72B | $7.05B | $6.45B | $6.37B | $6.31B | $6.17B | $6.07B |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | $10.02B | $9.32B | $9.23B | $9.28B | $9.12B |
| R&D | $366.0M | $355.0M | $343.0M | $320.0M | $307.0M | $290.0M | $281.0M | $277.0M | $285.0M | $289.0M |
| SG&A | $7.90B | $7.73B | $7.15B | $6.57B | $6.41B | $6.02B | $5.58B | $5.39B | $5.40B | $5.14B |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | $3.88B | $3.55B | $3.69B | $3.71B | $3.96B |
| Interest expense | $267.0M | $292.0M | $287.0M | $167.0M | — | — | — | — | — | — |
| Pre-tax income | $3.06B | $3.96B | $3.39B | $2.66B | $3.09B | $3.65B | $3.30B | $3.46B | $3.49B | $3.74B |
| Income tax | $798.0M | $907.0M | $937.0M | $693.0M | $749.0M | $787.0M | $774.0M | $906.0M | $1.31B | $1.15B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B | $2.69B | $2.37B | $2.40B | $2.02B | $2.44B |
| EPS, basic | 2.64 | 3.53 | 2.78 | 2.13 | 2.56 | 3.15 | 2.76 | 2.76 | 2.30 | 2.74 |
| EPS, diluted | 2.63 | 3.51 | 2.77 | 2.13 | 2.55 | 3.14 | 2.75 | 2.75 | 2.28 | 2.72 |
| Shares, diluted (wtd. avg.) | $811.1M | $823.2M | $829.2M | $838.8M | $848.3M | $859.3M | $861.1M | $873.0M | $887.8M | $898.4M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.29B | $1.10B | $966.0M | $775.0M | $832.0M | $888.0M | $883.0M | $726.0M | $1.53B | $1.31B |
| Short-term investments | $107.0M | $160.0M | $179.0M | — | — | — | — | — | — | — |
| Receivables | $1.68B | $1.52B | $1.59B | $1.50B | $1.30B | $1.26B | $1.44B | $1.40B | $1.48B | $1.41B |
| Inventory | $2.03B | $1.99B | $1.93B | $2.07B | $1.69B | $1.67B | $1.40B | $1.25B | $1.22B | $1.17B |
| Total current assets | $5.71B | $5.32B | $5.28B | $5.11B | $4.40B | $4.34B | $4.18B | $3.79B | $4.64B | $4.34B |
| Property, plant and equipment | $4.66B | $4.42B | $4.58B | $4.31B | $3.73B | $3.72B | $3.75B | $3.88B | $4.07B | $3.84B |
| Goodwill | $3.12B | $3.27B | $3.41B | $3.35B | $3.28B | $3.82B | $3.51B | $2.53B | $2.22B | $2.11B |
| Other intangibles | $1.54B | $1.76B | $1.89B | $1.92B | $2.46B | $2.89B | $2.67B | $1.64B | $1.34B | $1.31B |
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B | $15.92B | $15.03B | $12.16B | $12.68B | $12.12B |
| Accounts payable | $2.09B | $1.80B | $1.70B | $1.55B | $1.48B | $1.39B | $1.24B | $1.22B | $1.21B | $1.12B |
| Short-term debt | $1.11B | $652.0M | $20.0M | $14.0M | $12.0M | $9.0M | $254.0M | $0 | $0 | $0 |
| Total current liabilities | $6.85B | $5.76B | $4.74B | $4.00B | $4.05B | $4.40B | $4.04B | $3.34B | $3.41B | $3.31B |
| Long-term debt | $6.87B | $7.29B | $8.22B | $8.74B | $7.19B | $7.33B | $7.33B | $6.35B | $6.57B | $6.52B |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.93B | $14.07B | $14.82B | $14.48B | $11.96B | $12.43B | $12.11B |
| Retained earnings | $26.59B | $26.14B | $25.29B | $24.57B | $24.35B | $23.70B | $22.50B | $21.61B | $20.53B | $19.92B |
| Total equity | $54.0M | $212.0M | $609.0M | $401.0M | $609.0M | $743.0M | $117.0M | -$102.0M | -$60.0M | -$243.0M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.20B | $4.11B | $3.75B | $2.56B | $3.33B | $3.72B | $3.13B | $3.06B | $3.05B | $3.14B |
| Depreciation and amortisation | $630.0M | $605.0M | $567.0M | $545.0M | $556.0M | $539.0M | $519.0M | $511.0M | $475.0M | $443.0M |
| Stock-based compensation | $155.0M | $135.0M | $122.0M | $125.0M | $135.0M | $107.0M | $100.0M | $109.0M | $127.0M | $123.0M |
| Capital expenditure | $564.0M | $561.0M | $705.0M | $696.0M | $567.0M | $409.0M | $335.0M | $436.0M | $553.0M | $593.0M |
| Investing cash flow | -$817.0M | -$534.0M | -$742.0M | -$1.60B | -$592.0M | -$779.0M | -$2.10B | -$1.17B | -$471.0M | -$499.0M |
| Financing cash flow | -$3.26B | -$3.39B | -$2.79B | -$952.0M | -$2.77B | -$2.92B | -$870.0M | -$2.68B | -$2.45B | -$2.23B |
| Buybacks | $1.21B | $1.74B | $1.13B | $1.31B | $1.32B | $1.48B | $1.20B | $1.24B | $1.40B | $1.33B |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000021665-26-000006.
Others in SIC 2844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES INC | $37.63B | 207.7x | 5.0% |
| KVUE | Kenvue Inc. | $36.00B | 24.7x | -2.1% |
| ELF | e.l.f. Beauty, Inc. | $6.47B | 249.2x | 24.6% |
| IPAR | INTERPARFUMS INC | $3.74B | 22.3x | 2.5% |
| COTY | COTY INC. | $2.58B | — | -1.5% |
| EPC | EDGEWELL PERSONAL CARE Co | $1.33B | 54.5x | -1.3% |
| WALD | Waldencast plc | $156.3M | — | -0.7% |
| SLSN | SOLESENCE, INC. | $60.0M | 42.5x | 18.6% |